Sorry, you need to enable JavaScript to visit this website.

So far – So good!

You appear to meet the basic requirements for this COVID-19 Vaccine study. Please enter your information below to find a study location near you. Once you select a site, the research study staff will contact you to see if you qualify to enroll.

So far – So good!

Your child appears to meet the basic requirements for this COVID-19 vaccine study. However, only the research study staff can fully determine if your child qualifies to enroll. Please enter your contact information and select “Find a Site” to see if there is a study site enrolling in your area.

Note: Parents and guardians should input their contact information, not their child’s.

Sorry, you are not eligible at this time...

Thank you so much for your interest in this COVID-19 vaccine study and for answering our questions. Contact your healthcare provider if you have any medical questions. Also, please consider entering your information below to be contacted about future clinical research opportunities.

Sorry, you are not eligible at this time...

Thank you for your interest in this COVID-19 vaccine study and for answering our questions. Contact your healthcare provider if you have any medical questions. Also, please consider entering your information below to be contacted about future clinical research opportunities.

Parents and Children: Thank you for your interest to join the fight against COVID‑19

The Pfizer & BioNTech COVID-19 Vaccine Pediatric study is underway. Please note that study site locations are no longer accepting referrals for 5 to 11 year-olds.

Header

Question 1 of 2

A parent or guardian should answer the following questions on their child’s behalf.

Is your child between the ages of 6 months and 5 years old?

Question 2 of 2

Has your child participated in any clinical trial for COVID-19?

Please select a full valid address.

Choose a Location

Please select a research site near you. If you don't see a site near you, then select "The sites listed here are not convenient for me." Study locations are being added regularly. A study representative will call you if a research site becomes available in your area.

The sites listed here are not convenient for me.

About The Study

The Pfizer & BioNTech COVID-19 Vaccine Pediatric study for children 6 months to 11 years old first began in March 2021. The study compares the study vaccine against a placebo (injection with no active ingredient) to learn if the vaccine can produce an immune response against COVID-19, and if it is safe, in children 6 months to 11 years old. The study includes three age groups: 5 to 11 year-olds; 2 to 5 year-olds; and 6 months to 2 year-olds. All participants are given the opportunity to receive the COVID-19 study vaccine during their time in the trial. Participation in the study lasts approximately two years.

With Gratitude
 

An unprecedented number of courageous families, like yours, have raised their hands to be volunteers and help make a difference in the fight against COVID-19. We are deeply grateful for your interest.

While study site locations continue to enroll participants into the study, the sites have many more interested families than are needed to support the 5 to 11 year-old age group. Therefore, they are no longer accepting additional referrals.

For families with children between 6 months and 5 years old interested in volunteering, please share your contact information by clicking the “Get Started” button and answering a few questions. We ask for your patience as our study site locations are continuously evaluating their need for additional referrals.

Acting with Urgency
 

While we recognize the possibility of not being able to participate in the study may be disappointing, Pfizer and BioNTech are working diligently to gather the data that could help support the decision by regulatory authorities to make the vaccine available to families worldwide eagerly awaiting a possible vaccine option for children aged 6 months to 11 years. Pfizer and BioNTech expect to have the safety and immunogenicity data that could potentially support an Emergency Use Authorization (EUA) submission for use in children ages 5 to 11 years old in the fall of 2021.

The FDA may issue an Emergency Use Authorization (EUA) when certain criteria are met, which includes that there are no adequate, approved, available alternatives. The issuance of an EUA is based on the totality of scientific evidence available showing that the product may be effective to prevent COVID-19 and that the known and potential benefits of the product outweigh the known and potential risks. All of these criteria must be met to allow for use of the product.

Header Image

What to Expect

icon

All participants will have the opportunity to receive the COVID-19 study vaccine during their time in the trial.

icon

Over the course of this 2 year study, your child will have planned follow-up visits.

icon

You and your child will need to track any side effects they may have. To make it easier, you will be given an electronic diary (e-diary). If you prefer, you can also download a secure app on your smartphone.

icon

You will be reimbursed for expenses (such as parking, meals, travel) and time related to completing the e-diary.

Header Image
Pfizer Logo
BioNTech Logo